SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-011420
Filing Date
2023-07-24
Accepted
2023-07-24 17:10:43
Documents
1
Period of Report
2023-07-21

Document Format Files

Seq Description Document Type Size
1 form4-07242023_090735.html 4  
1 form4-07242023_090735.xml 4 4447
  Complete submission text file 0001415889-23-011420.txt   6048
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAPRICOR THERAPEUTICS, INC. 10865 ROAD TO THE CURE, SUITE 150 SAN DIEGO CA 92121
Business Address
Gotwals Philip J (Reporting) CIK: 0001982655 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 231105799